Surveillance Screenings and Medical Monitoring for Employers
The worker cutting concrete on your job site today will not develop silicosis today. He will develop it in eight years. The welder grinding stainless steel will not present with hexavalent chromium-related lung cancer this quarter. She will be presented with it in fifteen years. The maintenance technician removing lead paint in your facility will not show renal damage on this week’s blood panel. He will show it after cumulative exposure that nobody tracked, nobody measured, and nobody connected to his job duties – because no medical surveillance program was running.
OSHA medical surveillance exists because occupational diseases are preventable, but only if they are detected before the damage becomes permanent. Surveillance is the system of baseline, periodic, and exit medical examinations designed to catch the biological signal of occupational exposure – the declining FVC, the rising blood lead level, the shifting audiometric threshold, the abnormal differential white cell count – while intervention can still change the outcome. By the time the worker has symptoms, the surveillance program has already failed.Â
Occucare International designs and manages complete OSHA medical surveillance programs for employers in Houston and across Texas – covering every substance-specific standard that applies to your workforce’s exposure profile. Silica, lead, asbestos, noise, benzene, hexavalent chromium, cadmium, formaldehyde, and every other regulated hazard your employees encounter. Baseline examinations at assignment. Periodic monitoring at the intervals each standard mandates. Exit evaluations at separation. Every result reviewed by board-certified occupational medicine physicians who interpret findings in the context of your employees’ specific exposure history and job demands – not by laboratory software generating automated normal/abnormal flags.
OSHA Substance-Specific Compliance
Board-Certified Physician Review
Medical Removal Protection Management
Baseline → Periodic → Exit Protocol
Multi-Hazard Program Coordination
Population-Level Surveillance Trending
Clinic Hours
- Monday - Friday 7:30 AM - 4:30 PM CST
- +1 713 802 0801
Who Occucare Provides Medical Surveillance Programs To
Occucare designs and manages OSHA medical surveillance programs for construction general contractors and heavy civil firms with silica, lead, asbestos, and noise exposure across active project sites; industrial manufacturers with hexavalent chromium, cadmium, formaldehyde, and noise exposure in welding, plating, and chemical processing operations; oil and gas and energy operators with benzene, noise, and respiratory hazard exposure across upstream, midstream, and downstream facilities; abatement and remediation contractors operating under the most stringent multi-hazard surveillance requirements in any industry; and government and DoD contractors whose surveillance documentation must satisfy both OSHA substance-specific standards and contract-specific audit requirements. Across all of these segments, baseline, periodic, and exit surveillance is conducted by board-certified occupational medicine physicians under one integrated program – covering every OSHA substance-specific standard applicable to the employer’s exposure profile, from the Occucare Houston clinic and through onsite deployment to the workforce.
What Happens When Medical Surveillance Programs Are Missing, Incomplete, or Disconnected From Clinical Oversight
Most employers with regulated hazard exposure have some awareness that medical surveillance is required. The gap between awareness and execution is where occupational disease develops undetected, OSHA citations accumulate, and employers discover that the surveillance program documented in their safety manual bears no resemblance to what is actually being delivered. If any of the following describes your current surveillance infrastructure, your program has gaps that a physician-governed occupational health program is designed to close.
A Written Program That Exists on Paper but Not in Practice
The most dangerous surveillance program is one that is documented in the employer’s safety manual but not systematically executed. The safety manual says silica-exposed workers receive medical surveillance within 30 days of initial assignment and every three years thereafter. In practice, baseline exams are completed for some workers and not others. Periodic exams are scheduled when someone remembers, not when the regulatory interval requires them. Exit exams are almost never performed because the employee’s last day is too chaotic for compliance testing.Â
This employer is in a worse legal and regulatory position than an employer with no documented program at all. The written program proves the employer knew the requirement existed. The execution gap proves the employer failed to meet it. During an OSHA enforcement action or an occupational disease claim, the employer’s own safety manual becomes evidence of knowing non-compliance – transforming what might have been a standard serious violation into a potential willful violation with penalty exposure exceeding $163,000 per instance.
Surveillance Exams Performed Without Exposure Context
A surveillance exam is only clinically meaningful when the physician interpreting the results knows what the employee is exposed to, at what concentration, for how long, through what route of exposure, and what job tasks generate the exposure. When surveillance exams are performed at a general clinic with no connection to the employer’s industrial hygiene data, the physician reviews laboratory values against generic reference ranges without any occupational context.Â
A blood lead level of 25 µg/dL is clinically unremarkable in a general medicine context. In the context of an employee performing lead abatement with a documented airborne exposure at 40 µg/m³, that same result is a surveillance finding that triggers enhanced monitoring and approaches the threshold for medical removal. The laboratory value is identical. The clinical significance depends entirely on the occupational context that a general clinic does not have and a physician-governed surveillance program provides.
No Longitudinal Tracking - Each Exam Interpreted in Isolation
Medical surveillance is a longitudinal program. Its clinical value comes from tracking the same employee’s health indicators over time against their own baseline – detecting the trend that reveals occupational exposure effect before any single measurement is abnormal enough to trigger a clinical alert.
When surveillance exams are performed at different clinics, by different providers, with results stored in different systems, no physician has access to the longitudinal record. Each exam is interpreted in isolation. A blood lead level that has risen from 8 to 18 to 25 over three annual exams shows a clear upward trend that demands intervention. But if each exam was interpreted independently against a static reference range, all three results were reported as “normal” – and the rising exposure signal was invisible until the level crossed the medical removal threshold.
No Exit Surveillance - No Endpoint Documentation for Future Claims
Exit surveillance is the final measurement that documents the employee’s health status at the point of separation from exposure. It is the employer’s primary defense against future occupational disease claims from former employees. Without exit surveillance, the employer cannot demonstrate what the employee’s lead level, lung function, hearing threshold, or blood counts looked like when they left. If that employee develops symptoms five or ten years later, the absence of exit data creates a presumption that the exposure was ongoing and unmonitored throughout employment – regardless of whether the employer had a surveillance program for current employees.
Medical Removal Decisions Made Without Physician Governance
Several OSHA substance-specific standards include medical removal protection (MRP) provisions that require employers to temporarily remove employees from exposure when surveillance findings reach defined trigger levels – and to maintain the employee’s earnings and benefits during removal. Lead removal is triggered when blood lead levels reach 50 µg/dL in general industry or 50 µg/dL in construction (with return at 40 µg/dL). Cadmium removal is triggered by biological monitoring results indicating excessive absorption.
When medical removal decisions are made without a physician governing the surveillance program, two costly errors occur. First, removal is delayed because the trigger level is reached but nobody with clinical authority acts on the finding – the employer continues exposure while the laboratory result sits in an inbox. Second, return from removal is authorized without the physician confirmation that the applicable standard requires – creating regulatory non-compliance that is documented in the surveillance record itself. A physician-governed surveillance program ensures that medical removal is activated at the trigger, managed during the removal period, and terminated only when the return criteria defined by the standard are met.
Multi-Hazard Exposure Managed as Separate, Uncoordinated Programs
A construction worker cutting concrete (silica exposure), working near active welding (hexavalent chromium and noise exposure), and removing existing lead paint (lead exposure) on the same project is subject to three separate substance-specific surveillance standards simultaneously. When each standard is managed by a separate vendor with no clinical coordination, the worker completes three separate exams at three separate facilities with three separate physicians who have no knowledge of the other exposures.
The physician managing the silica surveillance does not know about the lead exposure. The physician reviewing the audiometric results does not know about the chromium exposure. The employer has three compliance files and no integrated clinical picture. At Occucare, multi-hazard surveillance is managed under one program, by one physician team, with one integrated medical record that connects every exposure, every finding, and every recommendation to the employee’s complete occupational health profile.
What OSHA Medical Surveillance Is - And Why It Is Fundamentally Different From General Employee Health Screening
OSHA Medical Surveillance Defined
OSHA medical surveillance is the systematic, ongoing medical monitoring of employees exposed to specific regulated workplace hazards, conducted at intervals defined by substance-specific OSHA standards, to detect early biological evidence of occupational exposure before clinical disease develops. Programs include baseline examinations at the onset of exposure, periodic examinations at standard-defined intervals, and exit examinations at separation. All findings are reviewed by an occupational medicine physician.
The Difference Between Medical Surveillance and General Health Screening
General employee health screening - wellness checks, annual physicals, biometric screenings - evaluates the employee’s overall health status. It is voluntary, employer-initiated, and not tied to specific regulatory requirements. It does not include exposure-specific testing, physician interpretation against occupational exposure data, or the medical removal authority that OSHA substance-specific standards provide.
Medical surveillance is targeted, mandatory, and exposure-specific. Each component of the surveillance examination exists because a specific OSHA standard requires it for a specific hazard exposure. The spirometry is performed because the employee is exposed to a substance that damages lung tissue. The blood lead level is drawn because the employee handles a substance that accumulates in the blood and damages organs. The audiometric test is conducted because the employee works in an environment loud enough to cause permanent hearing loss. The testing is not discretionary. The physician interpretation is not optional. And the employer’s obligation to act on the findings - including medical removal when triggered - is a regulatory mandate, not a best practice recommendation.
Occucare’s Hazard-Specific Medical Surveillance Programs - What Each Standard Requires and What Each Exam Includes
Occucare manages surveillance programs for every OSHA substance-specific standard that applies to your workforce. Each program below details the regulatory citation, the exposure trigger for surveillance eligibility, the examination components mandated by the standard, and the physician review and employer reporting protocol.
01 - Respirable Crystalline Silica
Standard: 29 CFR 1926.1153 (construction) / 29 CFR 1910.1053 (general industry)
Exposure trigger: Employees exposed at or above the action level (25 µg/m³ as an 8-hour TWA) for 30 or more days per year
PEL: 50 µg/m³ as an 8-hour TWA
The silica standard is the most recently promulgated major OSHA health standard and the one with the broadest impact on construction and industrial employers. Silica surveillance is triggered at the action level – half the PEL – which means employees with moderate exposure that does not exceed the permissible limit may still require surveillance.
Occucare’s silica surveillance program includes:
- Medical and work history with emphasis on respiratory system function, history of silica exposure at current and prior employers, and tobacco use history
- Physical examination with attention to the pulmonary and cardiovascular systems
- Chest X-ray (PA view) at initial exam and at least every three years thereafter – interpreted for evidence of silicotic nodules, progressive massive fibrosis, and other parenchymal abnormalities
- Pulmonary function testing (spirometry) at initial exam and at least every three years – measuring FVC, FEV1, and FEV1/FVC ratio with comparison against the employee’s individual baseline
- TB testing as determined by the physician based on the employee’s risk profile – silicosis increases susceptibility to tuberculosis
- Physician written medical opinion to the employer and the employee, including any recommended limitations on respirator use or work exposure, and any recommended additional medical evaluations
- Common exposure sources: concrete cutting, grinding, drilling, sawing; masonry work; sandblasting; tunneling; stone countertop fabrication; demolition
02 - Lead
Standard: 29 CFR 1926.62 (construction) / 29 CFR 1910.1025 (general industry)
Exposure trigger: Employees exposed to airborne lead at or above the action level (30 µg/m³ as an 8-hour TWA)
PEL: 50 µg/m³ as an 8-hour TWA
Lead surveillance is the most clinically complex OSHA surveillance program because it requires biological monitoring – blood testing that directly measures lead absorption into the body, not just airborne exposure. The blood lead level is the primary surveillance metric, and it triggers specific employer obligations at defined thresholds.
Occucare’s lead surveillance program includes:
- Blood lead level (BLL) monitoring: Initial blood lead level at baseline. Under the general industry standard, BLL monitoring is conducted at least every six months for all employees covered by surveillance, increasing to at least every two months for any employee whose most recent BLL is at or above 40 µg/dL – continuing at that frequency until two consecutive BLLs fall below 40 µg/dL. Under the construction standard, BLL monitoring is conducted at least every two months for the first six months of exposure and every six months thereafter for employees with BLL below 40 µg/dL, increasing to every two months when BLL reaches 40 µg/dL or higher. For any employee in medical removal status, BLL monitoring continues monthly throughout the removal period.Â
- Zinc protoporphyrin (ZPP) or free erythrocyte protoporphyrin (FEP) testing – a secondary indicator of lead’s effect on heme synthesis, providing additional biological exposure data
- Complete medical examination for employees with BLL at or above 40 µg/dL (general industry) or as determined by the physician for construction employees – including detailed medical and work history, physical examination with attention to neurological, gastrointestinal, and renal systems, and blood chemistry including BUN, creatinine, and complete blood count
- Medical removal management: Medical removal is triggered under different criteria depending on the applicable standard. Under the general industry standard (29 CFR 1910.1025), removal is required when a confirmed blood lead level reaches 60 µg/dL on a single test, or when the average of the three most recent blood lead determinations (or all determinations over the prior six months, whichever covers the longer period) equals or exceeds 50 µg/dL. Under the construction standard (29 CFR 1926.62), removal is required when a single blood lead test reaches 50 µg/dL. Under both standards, the employer must remove the employee from lead exposure and maintain earnings and benefits under medical removal protection. Return to the exposed position is authorized only when blood lead levels fall below 40 µg/dL on two consecutive tests. OccuCare manages the removal decision, monitors the employee during the removal period with serial BLL testing, and authorizes return when the standard’s return criteria are met.
- Physicians write medical opinions to the employer, including any detected condition that would increase the employee’s risk from lead exposure and any recommended limitations.
03 - Asbestos
Standard: 29 CFR 1926.1101 (construction) / 29 CFR 1910.1001 (general industry)
Exposure trigger: Employees exposed at or above the PEL (0.1 f/cc as an 8-hour TWA) or excursion limit (1.0 f/cc as a 30-minute average)
Asbestos surveillance carries the highest long-term liability of any substance-specific program because of the latency period between exposure and disease. Mesothelioma can develop 20 to 50 years after asbestos exposure. The surveillance records created today may be the primary evidence in a litigation proceeding decades from now.
Occucare’s asbestos surveillance program includes:
- Pre-placement examination before first asbestos exposure – establishing the complete health baseline before occupational exposure begins
- Annual examination for all employees exposed at or above the PEL or excursion limit, including complete medical and occupational history, physical examination, and respiratory system evaluation
- Chest X-ray (PA view): At initial exam, then as determined by OSHA guidelines and physician judgment. All chest radiographs interpreted by a NIOSH-certified B-reader using the ILO International Classification of Radiographs of Pneumoconioses – the standardized interpretation system that detects the parenchymal and pleural abnormalities characteristic of asbestosis and asbestos-related pleural disease
- Pulmonary function testing (spirometry) at initial exam and annually – detecting the restrictive pattern characteristic of asbestosis
- Complete occupational history documentation including all prior asbestos exposure at previous employers – critical for establishing cumulative exposure and for future claim defense
- Common exposure sources: demolition, renovation of pre-1980 buildings, insulation removal, pipe fitting, shipyard work, brake repair (historical), roofing, floor tile removal
04 - Noise (Hearing Conservation)
Standard: 29 CFR 1910.95 (general industry) / applied to construction through general duty clause and specific project requirements
Exposure trigger: Employees exposed to noise at or above 85 dBA as an 8-hour TWA (action level)
Noise-induced hearing loss is the most prevalent occupational disease in the United States and the single most commonly cited OSHA health standard. It is also the most preventable – when the audiometric surveillance program detects threshold shifts early enough for exposure modification and hearing protection intervention.
Occucare’s hearing conservation surveillance program includes:
- Baseline audiogram within six months of first exposure at or above 85 dBA (or within one month if mobile audiometric testing is not used). The baseline is the reference point against which all subsequent audiograms are compared.
- Annual audiometric testing for all employees in the hearing conservation program – compared against the employee’s baseline to identify Standard Threshold Shift (STS): an average decline of 10 dB or more at 2000, 3000, and 4000 Hz in either ear
- STS determination and employer notification: When an STS is identified, Occucare’s physician reviews the finding, determines whether the shift is persistent or temporary, evaluates whether age correction is appropriate, and notifies the employer and the employee within 21 days. OSHA requires the employer to fit or refit hearing protection, train the employee on its use, and refer the employee for further audiological evaluation if necessary.
- Baseline revision determination: When an STS is confirmed as persistent, the physician determines whether the baseline audiogram should be revised to the current audiogram – a clinical and regulatory decision that affects all future STS calculations for that employee.
- Hearing conservation program support: Beyond audiometric testing, OSHA requires employers to implement a complete hearing conservation program including noise monitoring, hearing protection selection and fit, and annual training. Occucare’s physicians advise on the clinical findings that inform hearing protection selection and program effectiveness evaluation.
05 - Benzene
Standard: 29 CFR 1910.1028
Exposure trigger: Employees exposed at or above the action level (0.5 ppm as an 8-hour TWA) for 30 or more days per year
PEL: 1 ppm as an 8-hour TWA; 5 ppm as a 15-minute STEL
Benzene is a known human carcinogen that causes leukemia and other hematological malignancies. Benzene surveillance focuses on hematological monitoring to detect the early blood cell changes that precede malignancy.
Occucare’s benzene surveillance program includes:
- Pre-assignment examination including medical history, physical examination, and complete blood count (CBC) with differential white blood cell count establishing hematological baseline
- Annual monitoring with CBC and differential for all exposed employees – physician review of any abnormal hematological trends against the employee’s baseline and exposure history
- Additional evaluation when abnormal hematological findings are detected – including repeat CBC, specialist referral, and physician determination of whether the finding is exposure-related and whether medical removal is indicated
- Emergency/exposure incident evaluation for employees involved in spill, leak, or emergency response events involving benzene exposure above the PEL
06 - Hexavalent Chromium
Standard: 29 CFR 1910.1026
Exposure trigger: Employees exposed at or above the action level (2.5 µg/m³ as an 8-hour TWA)
PEL: 5 µg/m³ as an 8-hour TWA
Hexavalent chromium is a potent respiratory carcinogen and a cause of occupational nasal and lung cancer, nasal septum perforation, and chrome ulcers. Surveillance focuses on respiratory system monitoring and dermal examination.
Occucare’s hexavalent chromium surveillance program includes:
- Medical examination within 30 days of initial assignment including medical and occupational history, physical examination with attention to the respiratory system and skin, and any additional tests the physician deems necessary based on exposure type and duration
- Annual examination for all employees exposed at or above the action level – with physician review of respiratory symptoms, nasal examination for septum perforation, skin examination for chrome ulcers, and spirometry where indicated
- Post-emergency examination within 30 days of any event involving exposure above the PEL without adequate respiratory protection
- Physician written medical opinion to the employer and employee with any recommended work limitations
- Common exposure sources: welding on stainless steel or chromium-containing alloys, chrome plating, thermal cutting of chromium-containing metals, painting with chromate-containing primers, cement production
07 - Cadmium
Standard: 29 CFR 1910.1027
Exposure trigger: Employees exposed at or above the action level (2.5 µg/m³ as an 8-hour TWA)
PEL: 5 µg/mÂł as an 8-hour TWAÂ
Cadmium surveillance is the most biologically complex OSHA program, requiring both air monitoring data and biological monitoring results to determine surveillance frequency and medical removal triggers.
Occucare’s cadmium surveillance program includes:
- Biological monitoring: Blood cadmium level (CdB), urine cadmium level (CdU), and beta-2-microglobulin (B2M) in urine – at baseline, annually, and at increased frequency when levels approach action thresholds
- Medical examination: Complete physical examination with emphasis on renal function (BUN, creatinine, urinalysis), pulmonary function (spirometry), and hepatic function
- Medical removal management: Cadmium’s medical removal provisions are the most detailed in any OSHA standard, with removal triggered by biological monitoring results, physician recommendation, or employee request based on symptoms. Occucare manages the entire removal, monitoring, and return process under physician governance.Â
08 - Formaldehyde
Standard: 29 CFR 1910.1048
Exposure trigger: Employees exposed at or above the action level (0.5 ppm as an 8-hour TWA) or above the STEL (2 ppm as a 15-minute exposure)
Formaldehyde is a sensitizing agent and probable human carcinogen. Surveillance includes physical examination, medical and exposure history, pulmonary function testing where indicated, and assessment for signs of formaldehyde sensitization including respiratory and dermal symptoms. Occucare manages formaldehyde surveillance with attention to the sensitization risk that makes even low-level exposure clinically significant once sensitization is established.Â
Common exposure sources: laboratories, mortuaries, hospitals, manufacturing of resins and adhesives, wood product manufacturing, textile finishing
How Occucare’s Medical Surveillance Program Works - From Exposure Assessment Through Ongoing Management
Step 1
Exposure Assessment and Standard Identification
Before any surveillance exam is scheduled, Occucare’s occupational health team reviews your industrial hygiene data, job hazard analyses, safety data sheets, air monitoring results, and job task descriptions to identify which substance-specific OSHA standards apply to which employees in your workforce. The assessment determines the specific surveillance program required for each hazard exposure, the examination components mandated by each applicable standard, the testing intervals defined by each standard, the medical removal trigger levels and return criteria for standards with MRP provisions, and which employees are eligible for surveillance based on exposure levels relative to the action level and PEL.
Step 2
Integrated Program Design
For employers with employees exposed to multiple regulated hazards simultaneously – which is the norm in construction, manufacturing, and energy – Occucare designs an integrated surveillance program that satisfies every applicable standard without redundant testing or separate vendor coordination. A worker exposed to silica, noise, and hexavalent chromium on the same project receives one coordinated surveillance program with all three substance-specific components managed by one physician team under one integrated medical record.
Step 3
Baseline Examinations
Every employee entering a covered position completes baseline surveillance examinations within the timeframe mandated by each applicable standard – within 30 days of initial assignment for silica and hexavalent chromium, before first exposure for asbestos, within six months for audiometric baseline. The baseline establishes the employee’s pre-exposure health status and creates the reference point against which all future periodic results are compared.
Step 4
Periodic Monitoring and Physician Review
Testing is conducted at the intervals defined by each applicable standard. Occucare manages the testing calendar for every employee in the program, sends proactive renewal notifications before testing intervals expire, and coordinates multi-standard testing into consolidated appointments where possible. Every result is reviewed by Occucare’s board-certified occupational medicine physician against the employee’s individual baseline, their longitudinal trend, their exposure history, and the clinical significance thresholds defined by each standard.
Step 5
Employer Reporting and Physician Written Medical Opinion
Each substance-specific standard defines the information the physician must communicate to the employer and the employee. Occucare provides the physician written medical opinion required by each standard – including any detected conditions that increase the employee’s risk from the exposure, any recommended limitations on work or respirator use, and any recommended additional medical evaluations. Employer reporting is formatted for your safety team’s operational needs, not for a patient chart.
Step 6
Medical Removal Management
When surveillance findings trigger medical removal under a standard with MRP provisions, Occucare’s physicians manage the entire removal process: making the removal determination based on defined trigger criteria, communicating the removal requirement to the employer with the specific exposure restrictions, monitoring the employee during the removal period with serial testing at defined intervals, and authorizing return to the exposed position only when the standard’s return criteria are met. Occucare also advises employers on their medical removal protection benefits obligations – the earnings and benefits maintenance requirements that apply during the removal period.
Step 7
Exit Examinations
When an employee separates from a covered position – whether through termination, transfer, retirement, or company departure – Occucare schedules and administers exit surveillance examinations that document the employee’s health status at the point of separation. The exit exam includes all components required by the applicable standard and is compared against the employee’s baseline and longitudinal record to produce a physician summary of the employee’s surveillance trajectory during their exposure period.
Do you know which OSHA substance-specific surveillance standards actually apply to your workforce - and whether your current program is meeting all of them?
Request a Surveillance Program Gap Assessment. Occucare’s occupational medicine team reviews your industrial hygiene data, air monitoring results, job hazard analyses, and current surveillance records against the applicable OSHA substance-specific standards – identifying which standards apply, which employees are covered, where baseline and periodic testing gaps exist, and where medical removal protection obligations may be unmanaged.
Fragmented Surveillance vs. Occucare’s Physician-Governed Medical Surveillance Program
| Capability | Fragmented / Retail Surveillance | Occucare Managed Program |
| Exposure context | Results interpreted without IH data | Physician interprets against exposure history and IH data |
| Longitudinal tracking | Each exam isolated – no trend analysis | Baseline-to-exit tracking with trend analysis |
| Multi-hazard coordination | Separate vendors per hazard | Integrated program – all standards, one physician team |
| Medical removal management | Employer manages ad hoc | Physician-governed: trigger, removal, monitoring, return |
| Exit surveillance | Rarely performed | Standard component with longitudinal summary |
| Physician written medical opinion | Generic clearance letter | Standard-specific opinion with limitations and recommendations |
| Testing schedule management | Employer tracks on spreadsheets | Proactive notifications per standard-defined intervals |
| Population-level trending | Not available | Workforce-wide trends identify systemic exposure issues |
| Integration with PFT/fit testing | Separate vendors | Coordinated with PFT and respirator clearance |
| Integration with injury management and RTW | None – surveillance vendor data does not flow into injury or RTW decisions | Surveillance findings flow into the same physician-governed framework managing injury cases, fitness-for-duty, and return-to-work determinations |
| OSHA audit readiness | Records assembled after audit notice | Audit-ready at all times – complete record per employee |
Population-Level Surveillance Trending - Detecting Systemic Exposure Problems Before Individual Cases Become Occupational Disease
Individual surveillance tracks one employee’s health over time. Population-level surveillance trending tracks your entire exposed workforce – identifying patterns that indicate systemic exposure problems the individual record may not reveal.Â
When Occucare’s physicians review surveillance data across your workforce population, they can identify:
Population trending transforms medical surveillance from a compliance program that detects individual disease into a risk management tool that identifies systemic exposure failures. The value to the employer is not just preventing occupational disease in individual workers – it is preventing the exposure conditions that would eventually produce occupational disease across the entire exposed population.
Rising average blood lead levels across a crew or facility – indicating an exposure source that is not adequately controlled, before any individual worker reaches the medical removal threshold
Clustered audiometric threshold shifts in a specific department or job classification – indicating a noise source that the hearing conservation program is not adequately addressing
Declining average spirometry values in silica-exposed crews – indicating that dust control measures are insufficient at a systemic level, before any individual worker’s decline reaches clinical significance
Hematological trend shifts in benzene-exposed populations – identifying early patterns that may indicate cumulative exposure effect across the workforce
The Financial Case for Physician-Governed Medical Surveillance
OSHA Citation Exposure
Failure to provide required medical surveillance is a citable violation under every substance-specific OSHA standard. For the silica standard alone, OSHA can cite failure to provide initial medical examination, failure to provide periodic examination, failure to provide chest X-ray, failure to provide pulmonary function testing, and failure to provide the physician written medical opinion - each as a separate violation, for each affected employee. At current penalty rates exceeding $16,000 per serious violation, an employer with 25 silica-exposed workers and no surveillance program faces theoretical citation exposure in the hundreds of thousands of dollars before any actual occupational disease is identified.
Occupational Disease Claim Costs
Occupational lung disease claims (silicosis, asbestosis), occupational cancer claims (benzene-related leukemia, chromium-related lung cancer), lead-related organ damage claims, and noise-induced hearing loss claims are among the most expensive categories in workers’ compensation. They produce permanent disability benefits, lifelong medical monitoring costs, and the legal fees associated with contested causation. A well-documented surveillance program either detects exposure effects early enough to prevent advanced disease through workplace intervention or provides the employer with a defensible record of compliance that limits liability when claims arise.
Medical Removal Costs - Managed vs. Unmanaged
Medical removal under OSHA MRP provisions requires the employer to maintain the removed employee’s earnings and benefits during the removal period. An employer with no surveillance program discovers the need for medical removal when the employee develops symptoms of advanced exposure - at which point the removal period is longer, the monitoring requirements are more intensive, and the return to exposure is less likely. An employer with a physician-governed surveillance program detects the rising biological indicator before it reaches the removal threshold, implements enhanced controls and exposure modification, and prevents the full medical removal scenario entirely - or, when removal is required, manages it as a brief, planned event rather than an emergency.
Why Occucare - Medical Surveillance as a Physician-Governed Clinical System, Not a Testing Service
Board-certified occupational medicine physicians reviewing every result
Not laboratory software. Not technician sign-off. Physician clinical judgment applied in the context of each employee’s specific exposure history, baseline values, and longitudinal trend.
Multi-hazard program coordination
Silica, lead, asbestos, noise, benzene, hexavalent chromium, cadmium, and formaldehyde managed under one integrated program. One physician team, one medical record, one employer reporting system.
Population-level trending
Workforce-wide surveillance data analyzed to detect systemic exposure problems before individual cases become occupational disease claims.
Medical removal management
Physician-governed medical removal from trigger detection through monitoring and return authorization - fully compliant with MRP provisions under lead, cadmium, and other applicable standards.
Longitudinal baseline-to-exit tracking
Every employee’s surveillance record maintained from initial assignment through separation - with physician summary reports that serve as defensible documentation for future claim proceedings.
Integration with PFT and respirator fit testing
Surveillance spirometry coordinated with respirator medical clearance. Surveillance findings connected to respiratory protection decisions under one clinical framework.
Onsite testing and multi-site delivery
Surveillance exams conducted at our Houston clinic, onsite at your facility, or through our 3,000+ clinic network. One program standard across every location.
Proactive compliance calendar
Testing intervals tracked per employee per standard. Renewal notifications sent before compliance lapses. No employee falls out of surveillance coverage because nobody tracked the date.
Frequently Asked Questions - Medical Surveillance for Employers
Occucare's onboarding for surveillance programs is designed to consolidate fragmented vendor records into one integrated program without losing the longitudinal data that makes surveillance clinically meaningful. Our team reviews your current surveillance records across every applicable substance-specific standard, imports prior baseline and periodic results into our integrated longitudinal tracking system as historical reference points, and schedules the next periodic examination at the interval mandated by each applicable standard. Employees with current valid baseline examinations and intervening periodic results are not retested unnecessarily - their prior records become the comparison points for future periodic and exit surveillance. For employers consolidating from three or four separate vendors managing silica, lead, audiometric, and respiratory surveillance independently, Occucare's physicians evaluate which prior results are clinically usable as longitudinal reference points and which need to be re-baselined under integrated program standards. The transition is managed without compliance gaps, without lost data, and without unnecessary retesting of valid existing records.
Surveillance requirements are determined by your employees’ exposure to OSHA-regulated substances relative to substance-specific action levels and permissible exposure limits. If your workforce handles, is exposed to, or works near crystalline silica, lead, asbestos, noise above 85 dBA, benzene, hexavalent chromium, cadmium, formaldehyde, or other regulated substances, you likely have surveillance obligations. Occucare’s physicians review your industrial hygiene data, air monitoring results, job task descriptions, and safety data sheets to determine exactly which standards apply and which employees are covered.
Occucare’s physicians evaluate the clinical significance of any abnormal finding in the context of the employee’s exposure history, baseline values, longitudinal trend, and the specific clinical threshold defined by the applicable OSHA standard. Depending on the finding, recommendations may include enhanced monitoring at increased frequency, additional diagnostic evaluation or specialist referral, temporary modification of work duties or exposure level, medical removal from the exposure source under the applicable standard’s MRP provisions, or engineering control and workplace modification recommendations communicated to the employer’s safety team. Every action recommendation is documented in the physician written medical opinion provided to the employer.
Yes. Occucare provides onsite medical surveillance for employers with large workforces or active construction projects. Onsite testing includes audiometry, spirometry, blood draws, physical examinations, and related testing conducted at your facility by trained technicians and occupational health clinicians. Onsite surveillance is frequently coordinated with respirator fit testing and PFT to consolidate multiple compliance testing requirements into a single deployment event.
Medical removal protection is an OSHA provision in certain substance-specific standards - primarily lead and cadmium - that requires employers to temporarily remove employees from exposure when biological monitoring results reach defined trigger levels, and to maintain the employee’s earnings and benefits during the removal period. Occucare’s physicians manage the complete medical removal process: identifying when surveillance results reach the trigger level, making the removal determination and communicating it to the employer, monitoring the employee with serial testing during the removal period, and authorizing return to the exposed position only when the standard’s return criteria are met. Occucare also advises employers on their MRP benefits obligations during the removal period.
Medical surveillance reduces employer costs through three mechanisms. First, early detection of exposure-related health effects enables workplace intervention before conditions progress to occupational disease - preventing the workers’ compensation claims, permanent disability costs, and legal fees that advanced occupational disease generates. Second, population-level surveillance trending identifies systemic exposure control failures before they produce individual disease cases - enabling engineering corrections that prevent claims across the entire exposed workforce. Third, well-documented surveillance records demonstrate the employer’s compliance with OSHA mandates and provide defensible documentation in claim proceedings, reducing the litigation exposure that accompanies every occupational disease allegation.
Medical surveillance at Occucare is one component of an integrated occupational health program governed by the same board-certified physicians who oversee pulmonary function testing, respirator medical clearance, corporate medical direction, and workplace injury management. Surveillance spirometry results inform respirator clearance decisions. Surveillance findings that indicate medical removal are coordinated with case management for return-to-work planning. Population-level surveillance trends are communicated to the corporate medical direction program for workforce health strategy decisions. This integration ensures that surveillance data does not sit in isolation but actively informs every occupational health decision made for your workforce.
Explore Related Occucare Services
Workplace Compliance Testing Hub
The complete employer compliance testing program: drug testing, respirator fit, PFT, cognitive screening, audiometric testing, and surveillance monitoring.
Pulmonary Function Testing
NIOSH-certified spirometry - the primary pulmonary surveillance component for silica, asbestos, and other respiratory hazard surveillance programs.
Respirator Fit Testing
OSHA 29 CFR 1910.134 fit testing coordinated with surveillance program respiratory evaluations.
OSHA Medical Surveillance
Comprehensive employer surveillance program management across all regulated hazard exposures.
Corporate Medical Direction
The physician governance framework connecting surveillance findings to workforce health strategy and risk management decisions.
Occupational Health Clinic Houston
Walk-in and scheduled surveillance exams, compliance testing, and employer clinic services.
Protect Your Workforce From Long-Term Exposure Damage - And Protect Your Company From the Costs of Missing It
The occupational diseases that medical surveillance detects — silicosis, lead poisoning, asbestosis, noise-induced hearing loss, benzene-related malignancy, chromium-related cancer – are irreversible once established. Surveillance is the only system that catches them early enough for intervention. Occucare International delivers physician-governed medical surveillance across every OSHA substance-specific standard that applies to your workforce — with baseline-to-exit tracking, multi-hazard program coordination, population-level trending, and medical removal management that keeps your employees protected and your company compliant.